GhadriJRWittsteinISPrasadA, et al.International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018;39:2032–46.
2.
BossoneESavareseGFerraraF, et al.Takotsubo cardiomyopathy: overview. Heart Fail Clin. 2013;9:249–66.
3.
ManfrediniRCappadonaRFabbianF. Is Takotsubo syndrome still a benign disease? Complications (and gender) make the difference. Angiology. 2019;70:795–6.
4.
ChopraVKAnkerSD. Anaemia, iron deficiency and heart failure in 2020: facts and numbers. ESC Heart Fail. 2020;7:2007–11.
5.
ChobufoMDRahmanEGayamV, et al.Prevalence and association of iron deficiency with anemia among patients with heart failure in the USA: NHANES 2017-2018. J Community Hosp Intern Med Perspect. 2021;11:124–7.
6.
YeSDWangSJWangGG, et al.Association between anemia and outcome in patients hospitalized for acute heart failure syndromes: findings from Beijing Acute Heart Failure Registry (Beijing AHF Registry). Intern Emerg Med. 2021;16:183–92.
7.
LawlerPRFilionKBDourianTAtallahRGarfinkleMEisenbergMJ. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J. 2013;165:143–53.
8.
ParkJYChoiBGRhaSWKangTS. Five-year outcomes in patients with anemia on admission undergoing a coronary intervention for acute myocardial infarction in Koreans: propensity score matching analysis. Coron Artery Dis. 2018;29:647–51.
9.
LuXLiPTengCCaiPWangB. Anemia is associated with poor clinical outcomes in hospitalized patients with takotsubo cardiomyopathy. Angiology. 2021;72:842–49.
10.
YerasiCTripathiBBangaS, et al.Predictors of 90-day readmission and in-hospital mortality in Takotsubo cardiomyopathy: an analysis of 28,079 index admissions. Cardiovasc Revasc Med. 2019;20:973–9.
11.
GaedeLHerchenbachATröbsMMarwanMAchenbachS. Left ventricular contraction patterns in Takotsubo syndrome and their correlation with long-term clinical outcome. Int J Cardiol Heart Vasc. 2021;32:100708.
12.
JentzerJCLawlerPRKatzJN, et al.Red blood cell transfusion threshold and mortality in cardiac intensive care unit patients. Am Heart J. 2021Jan23;S0002–8703(21)00019–3. doi:10.1016/j.ahj.2021.01.015 Online ahead of print
13.
ZhangJHuSJiangYZhouY. Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials. Postgrad Med J. 2020;96:766–76.
14.
PonikowskiPKirwanBAAnkerSD, et al;AFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396:1895–904.
